PIK3CA and neoplasm: In some cases, multiple ctDNA mutations exhibited similar AF dynamics, while in others, a ctDNA TP53 mutation not found in the initial tumor biopsy showed elevated levels after paclitaxel chemotherapy despite decrease of a PIK3CA mutation AF during stable disease.